loader
Please Wait
Applying Filters...

Seqens Seqens

X

Information, Expiry & Status of FDA Orange Book Patents covering Dabrafenib

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NOVARTIS (68)

filter

01 10869869*PED (2)

02 7994185 (9)

03 8415345 (9)

04 8703781 (9)

05 8835443 (9)

06 8952018 (2)

07 9233956 (8)

08 10869869 (2)

09 11504333 (1)

10 11504333*PED (1)

11 7994185*PED (3)

12 8415345*PED (3)

13 8703781*PED (3)

14 8835443*PED (3)

15 8952018*PED (2)

16 9233956*PED (2)

filter

01 Y (27)

02 Blank (41)

filter

01 Y (28)

02 Blank (40)

filter

01 2025-06-10 (9)

02 2025-12-10 (3)

03 2029-05-04 (8)

04 2029-11-04 (2)

05 2030-01-20 (18)

06 2030-07-20 (6)

07 2030-10-15 (11)

08 2031-04-15 (5)

09 2033-08-30 (2)

10 2034-03-02 (2)

11 2038-06-29 (1)

12 2038-12-29 (1)

URL Supplier Web Content
8835443
2025-06-10
U-2027
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8835443
2025-06-10
U-2298
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8835443
2025-06-10
U-2026
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9233956
2029-05-04
U-2032
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9233956
2029-05-04
U-2296
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7994185
Y
Y
2030-01-20
U-2296
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7994185
Y
Y
2030-01-20
U-2032
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7994185
Y
Y
2030-01-20
U-1406
202806
TREATMENT OF MELANOMA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8703781
Y
Y
2030-10-15
U-2296
202806
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8703781
Y
Y
2030-10-15
U-1713
202806
TAFINLAR IN COMBINATION WITH TRAMETINIB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY